Chlorpyrifos oxon activates glutamate and lysine for protein cross-linking

dc.contributor.authorMuñoz-Torrero López-Ibarra, Diego
dc.contributor.authorSchopfer, Lawrence M.
dc.contributor.authorLockridge, Oksana
dc.date.accessioned2023-02-22T11:55:29Z
dc.date.available2023-02-22T11:55:29Z
dc.date.issued2023
dc.date.updated2023-02-22T11:55:29Z
dc.description.abstractChronic low-dose exposure to organophosphorus (OP) toxicants is correlated with an increase in the risk of impaired cognition and neurodegenerative diseases. A mechanism to explain this relationship is needed. We suggest that the formation of organophosphate-induced high-molecular-weight protein aggregates that disrupt cell function may be the missing link. It has been demonstrated that such aggregation can be promoted by OP-labeled lysine. Alternatively, OP-labeled glutamate may be the initiator. To test this hypothesis, we treated MAP-rich tubulin Sus scrofa and human transglutaminase with chlorpyrifos oxon. Trypsin-digested proteins were subjected to liquid chromatography−tandem mass spectrometry followed by Protein Prospector searches to identify diethyl phosphate adducts and cross-linked peptides. We report the presence of diethyl phosphate adducts on the side chains of glutamate, lysine, and tyrosine, as well as cross-links between glutamate and lysine. Glutamate-lysine cross-linking could be initiated either by diethyl phosphate-activated glutamate or by diethyl phosphate-activated lysine to form stable isopeptide bonds between and within proteins. It was concluded that organophosphate-induced high-molecular-weight protein aggregates could promote brain dysfunction.
dc.format.extent10 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec728358
dc.identifier.issn0893-228X
dc.identifier.urihttps://hdl.handle.net/2445/193966
dc.language.isoeng
dc.publisherAmerican Chemical Society
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1021/acs.chemrestox.2c00333
dc.relation.ispartofChemical Research in Toxicology, 2023, vol. 36, num. 1, p. 112-121
dc.relation.urihttps://doi.org/10.1021/acs.chemrestox.2c00333
dc.rightscc by-nc-nd (c) Diego Muñoz-Torrero López-Ibarra, et al., 2023
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.sourceArticles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)
dc.subject.classificationMalalties neurodegeneratives
dc.subject.classificationPèptids
dc.subject.classificationProteïnes
dc.subject.classificationÀcids nucleics
dc.subject.otherNeurodegenerative Diseases
dc.subject.otherPeptides
dc.subject.otherProteins
dc.subject.otherNucleic acids
dc.titleChlorpyrifos oxon activates glutamate and lysine for protein cross-linking
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
728358.pdf
Mida:
4.13 MB
Format:
Adobe Portable Document Format